H-CYTE Inc logo

H-CYTE Inc

$ 5.99 0 (0%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 2.86M
Enterprise V:
$ 8.88M
Volume:
-
Avg Vol (2M):
138.00
Volume:
-
Market Cap $:
2.86M
PE Ratio:
At Loss
Avg Vol (2-Month):
138.00
Enterprise Value $:
8.88M
PB Ratio:
0
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.01
Equity-to-Asset -33.81
Debt-to-Equity -0.69
Debt-to-EBITDA -0.61
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -491.13
Distress
Grey
Safe
Beneish M-Score -11.24
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 99.5
9-Day RSI 92.17
14-Day RSI 72.78
6-1 Month Momentum % -73.13
12-1 Month Momentum % -85.63

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.03
Quick Ratio 0.03
Cash Ratio 0.01
Days Sales Outstanding 6.21
Days Payable 1049.24

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -88
Name Current Vs Industry Vs History
Gross Margin % 65.47
Operating Margin % -368.16
Net Margin % -1226.32
ROA % -2067.75
ROIC % -71.47
ROC (Joel Greenblatt) % -14304.35
Name Current Vs Industry Vs History
PS Ratio 1.31
EV-to-EBIT -0.96
EV-to-EBITDA -0.97
EV-to-Revenue 11.4
EV-to-FCF -3.36
Earnings Yield (Greenblatt) % -104.17

Financials

HCYT's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:HCYT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.779
EPS (TTM) ($) -40.01
Beta 0.29
Volatility % 104.59
14-Day RSI 72.78
14-Day ATR ($) 0.025115
20-Day SMA ($) 5.798
12-1 Month Momentum % -85.63
52-Week Range ($) 2.02 - 77
Shares Outstanding (Mil) 0.48

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

H-CYTE Inc Filings

Document Form Filing Date
No Filing Data

H-CYTE Inc Analysis

Share your research

Headlines

See More
No news.